610 related articles for article (PubMed ID: 22982207)
1. Synthesis and characterization of doxorubicin modified ZnO/PEG nanomaterials and its photodynamic action.
Hariharan R; Senthilkumar S; Suganthi A; Rajarajan M
J Photochem Photobiol B; 2012 Nov; 116():56-65. PubMed ID: 22982207
[TBL] [Abstract][Full Text] [Related]
2. The synergistic effect and mechanism of doxorubicin-ZnO nanocomplexes as a multimodal agent integrating diverse anticancer therapeutics.
Deng Y; Zhang H
Int J Nanomedicine; 2013; 8():1835-41. PubMed ID: 23674895
[TBL] [Abstract][Full Text] [Related]
3. Reduction-responsive disassemblable core-cross-linked micelles based on poly(ethylene glycol)-b-poly(N-2-hydroxypropyl methacrylamide)-lipoic acid conjugates for triggered intracellular anticancer drug release.
Wei R; Cheng L; Zheng M; Cheng R; Meng F; Deng C; Zhong Z
Biomacromolecules; 2012 Aug; 13(8):2429-38. PubMed ID: 22746534
[TBL] [Abstract][Full Text] [Related]
4. Sol-gel synthesis and characterizations of hybrid chitosan-PEG/calcium silicate nanocomposite modified with ZnO-NPs and (E102) for optical and antibacterial applications.
Youssef AM; El-Nahrawy AM; Abou Hammad AB
Int J Biol Macromol; 2017 Apr; 97():561-567. PubMed ID: 28108409
[TBL] [Abstract][Full Text] [Related]
5. A strategy for ZnO nanorod mediated multi-mode cancer treatment.
Zhang H; Chen B; Jiang H; Wang C; Wang H; Wang X
Biomaterials; 2011 Mar; 32(7):1906-14. PubMed ID: 21145104
[TBL] [Abstract][Full Text] [Related]
6. PEGylated and poloxamer-modified chitosan nanoparticles incorporating a lysine-based surfactant for pH-triggered doxorubicin release.
Scheeren LE; Nogueira DR; Macedo LB; Vinardell MP; Mitjans M; Infante MR; Rolim CM
Colloids Surf B Biointerfaces; 2016 Feb; 138():117-27. PubMed ID: 26674840
[TBL] [Abstract][Full Text] [Related]
7. Effect of PEG-PDLLA polymeric nanovesicles loaded with doxorubicin and hematoporphyrin monomethyl ether on human hepatocellular carcinoma HepG2 cells in vitro.
Xiang GH; Hong GB; Wang Y; Cheng D; Zhou JX; Shuai XT
Int J Nanomedicine; 2013; 8():4613-22. PubMed ID: 24324333
[TBL] [Abstract][Full Text] [Related]
8. Oxime linkage: a robust tool for the design of pH-sensitive polymeric drug carriers.
Jin Y; Song L; Su Y; Zhu L; Pang Y; Qiu F; Tong G; Yan D; Zhu B; Zhu X
Biomacromolecules; 2011 Oct; 12(10):3460-8. PubMed ID: 21863891
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and in vitro and in vivo evaluations of poly(ethylene glycol)-block-poly(4-vinylbenzylphosphonate) magnetic nanoparticles containing doxorubicin as a potential targeted drug delivery system.
Hałupka-Bryl M; Asai K; Thangavel S; Bednarowicz M; Krzyminiewski R; Nagasaki Y
Colloids Surf B Biointerfaces; 2014 Jun; 118():140-7. PubMed ID: 24769390
[TBL] [Abstract][Full Text] [Related]
10. Photoinduced Dynamics and Toxicity of a Cancer Drug in Proximity of Inorganic Nanoparticles under Visible Light.
Chaudhuri S; Sardar S; Bagchi D; Dutta S; Debnath S; Saha P; Lemmens P; Pal SK
Chemphyschem; 2016 Jan; 17(2):270-7. PubMed ID: 26563628
[TBL] [Abstract][Full Text] [Related]
11. Synergistic effect of chemo-photothermal for breast cancer therapy using folic acid (FA) modified zinc oxide nanosheet.
Vimala K; Shanthi K; Sundarraj S; Kannan S
J Colloid Interface Sci; 2017 Feb; 488():92-108. PubMed ID: 27821343
[TBL] [Abstract][Full Text] [Related]
12. Targeted delivery and controlled release of doxorubicin into cancer cells using a multifunctional graphene oxide.
Lv Y; Tao L; Annie Bligh SW; Yang H; Pan Q; Zhu L
Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():652-660. PubMed ID: 26652419
[TBL] [Abstract][Full Text] [Related]
13. Fabrication of poly(ethylene glycol)-coated mesoporous nanocomposite ZnO@Fe
Alavi AS; Meshkini A
Eur J Pharm Sci; 2018 Mar; 115():144-157. PubMed ID: 29353012
[TBL] [Abstract][Full Text] [Related]
14. ZnO-Based Nanoplatforms for Labeling and Treatment of Mouse Tumors without Detectable Toxic Side Effects.
Ye DX; Ma YY; Zhao W; Cao HM; Kong JL; Xiong HM; Möhwald H
ACS Nano; 2016 Apr; 10(4):4294-300. PubMed ID: 27018822
[TBL] [Abstract][Full Text] [Related]
15. Multifunctional lactobionic acid-modified dendrimers for targeted drug delivery to liver cancer cells: investigating the role played by PEG spacer.
Fu F; Wu Y; Zhu J; Wen S; Shen M; Shi X
ACS Appl Mater Interfaces; 2014 Sep; 6(18):16416-25. PubMed ID: 25185074
[TBL] [Abstract][Full Text] [Related]
16. Tumor pH-triggered "charge conversion" nanocarriers with on-demand drug release for precise cancer therapy.
Ma BA; Sun CY
J Mater Chem B; 2020 Oct; 8(40):9351-9361. PubMed ID: 32996552
[TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of magnetic gold nanoparticles to be used as doxorubicin nanocarriers.
Elbialy NS; Fathy MM; Khalil WM
Phys Med; 2014 Nov; 30(7):843-8. PubMed ID: 24950615
[TBL] [Abstract][Full Text] [Related]
18. Anticancer efficacy of photodynamic therapy with hematoporphyrin-modified, doxorubicin-loaded nanoparticles in liver cancer.
Chang JE; Yoon IS; Sun PL; Yi E; Jheon S; Shim CK
J Photochem Photobiol B; 2014 Nov; 140():49-56. PubMed ID: 25090224
[TBL] [Abstract][Full Text] [Related]
19. Visible light-induced singlet oxygen-mediated intracellular disassembly of polymeric micelles co-loaded with a photosensitizer and an anticancer drug for enhanced photodynamic therapy.
Saravanakumar G; Lee J; Kim J; Kim WJ
Chem Commun (Camb); 2015 Jun; 51(49):9995-8. PubMed ID: 25998105
[TBL] [Abstract][Full Text] [Related]
20. Synergistic chemo-photodynamic therapy mediated by light-activated ROS-degradable nanocarriers.
Chen Y; Gao Y; Li Y; Wang K; Zhu J
J Mater Chem B; 2019 Jan; 7(3):460-468. PubMed ID: 32254733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
